In an effort to foster greater transparency of healthcare costs, the government and private sector entities are offering tools that provide cost and quality information to consumers. But just how effective are these tools?
In an effort to foster greater transparency of healthcare costs, the government and private sector entities are offering tools that provide cost and quality information to consumers.
Just how effective are the tools offered by CMS? A new report from the Government Accountability Office (GAO) says that the government is failing to actually make healthcare costs more transparent.
GAO analyzed 5 transparency tools operated by CMS: Nursing Home Compare, Dialysis Facility Compare, Home Health Compare, Hospital Compare, and Physician Compare. Three other tools are under development: Hospice Quality Reporting, Inpatient Rehabilitation Facility Quality Reporting, and Long-Term Acute Care Hospital Quality Reporting.
After literature review and interviews with experts, GAO determined the information that is most relevant to consumers relates to their particular circumstances. As such, relevant information typically describes key differences in quality of care and costs.
“Transparency tools are most effective if they provide information relevant to consumers and convey information in a way that consumers can readily understand,” according to the report.
However, the tools already in place lack relevant information on cost, and data on the key differences in quality of care is limited, according to the GAO report. Furthermore, none of the tools provide information on out-of-pocket costs, so consumers cannot anticipate cost of services in advance. There was also an issue with the timeliness of the data being presented and the clarity of the language, according to the report.
Although CMS has taken some steps to expand access to cost and quality information, its process for selecting cost and quality measures for its tools has been influenced far more by providers rather than consumers.
“Without procedures or metrics focusing on consumer needs, CMS cannot ensure that these efforts will produce cost and quality information that is relevant and understandable to consumers seeking to make meaningful distinctions.”
Based on GAO’s research, more effective consumer transparency tools are:
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More
Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder
July 23rd 2025Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved claims.
Read More